Maasoumy B - Search Results

1

Viral and Host Responses After Stopping Long-term Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis B.

Höner Zu Siederdissen C, Rinker F, Maasoumy B, Wiegand SB, Filmann N, Falk CS, Deterding K, Port K, Mix C, Manns MP, Herrmann E, Wedemeyer H, Kraft AR, Cornberg M. Höner Zu Siederdissen C, et al. Among authors: maasoumy b. J Infect Dis. 2016 Nov 15;214(10):1492-1497. doi: 10.1093/infdis/jiw412. Epub 2016 Sep 7. J Infect Dis. 2016. PMID: 27609808

2

Welchen Leberpatienten droht Übles?

Griemsmann M, Maasoumy B. Griemsmann M, et al. Among authors: maasoumy b. MMW Fortschr Med. 2023 Mar;165(5):25. doi: 10.1007/s15006-023-2476-0. MMW Fortschr Med. 2023. PMID: 36894845 Review. German. No abstract available.

3

Induction of a mature hepatocyte phenotype in adult liver derived progenitor cells by ectopic expression of transcription factors.

Iacob R, Rüdrich U, Rothe M, Kirsch S, Maasoumy B, Narain N, Verfaillie CM, Sancho-Bru P, Iken M, Popescu I, Schambach A, Manns MP, Bock M. Iacob R, et al. Among authors: maasoumy b. Stem Cell Res. 2011 May;6(3):251-61. doi: 10.1016/j.scr.2011.02.002. Epub 2011 Feb 24. Stem Cell Res. 2011. PMID: 21474405 Free article.

4

Natural history of acute and chronic hepatitis C.

Maasoumy B, Wedemeyer H. Maasoumy B, et al. Best Pract Res Clin Gastroenterol. 2012 Aug;26(4):401-12. doi: 10.1016/j.bpg.2012.09.009. Best Pract Res Clin Gastroenterol. 2012. PMID: 23199500 Review.

5

Optimal treatment with boceprevir for chronic HCV infection.

Maasoumy B, Manns MP. Maasoumy B, et al. Liver Int. 2013 Feb;33 Suppl 1:14-22. doi: 10.1111/liv.12070. Liver Int. 2013. PMID: 23286841 Review.

6

Eligibility and safety of triple therapy for hepatitis C: lessons learned from the first experience in a real world setting.

Maasoumy B, Port K, Markova AA, Serrano BC, Rogalska-Taranta M, Sollik L, Mix C, Kirschner J, Manns MP, Wedemeyer H, Cornberg M. Maasoumy B, et al. PLoS One. 2013;8(2):e55285. doi: 10.1371/journal.pone.0055285. Epub 2013 Feb 1. PLoS One. 2013. PMID: 23383319 Free PMC article. Clinical Trial.

7

The clinical significance of drug-drug interactions in the era of direct-acting anti-viral agents against chronic hepatitis C.

Maasoumy B, Port K, Calle Serrano B, Markova AA, Sollik L, Manns MP, Cornberg M, Wedemeyer H. Maasoumy B, et al. Aliment Pharmacol Ther. 2013 Dec;38(11-12):1365-72. doi: 10.1111/apt.12523. Epub 2013 Oct 16. Aliment Pharmacol Ther. 2013. PMID: 24127648

8

Detection of low HCV viraemia by repeated HCV RNA testing predicts treatment failure to triple therapy with telaprevir.

Maasoumy B, Cobb B, Bremer B, Luk K, Halfon P, Aslam S, Manns MP, Cornberg M, Wedemeyer H. Maasoumy B, et al. Aliment Pharmacol Ther. 2014 Jan;39(1):85-92. doi: 10.1111/apt.12544. Epub 2013 Nov 10. Aliment Pharmacol Ther. 2014. PMID: 24206524

9

Commentary: detection of low level viraemia in telaprevir-based triple therapy for hepatitis C virus - authors' reply.

Maasoumy B, Wedemeyer H. Maasoumy B, et al. Aliment Pharmacol Ther. 2014 Mar;39(5):544-5. doi: 10.1111/apt.12642. Aliment Pharmacol Ther. 2014. PMID: 24494844 No abstract available.

10

How to interpret borderline HCV antibody test results: a comparative study investigating four different anti-HCV assays.

Maasoumy B, Bremer B, Raupach R, Lehmann P, Manns MP, Cornberg M, Wedemeyer H. Maasoumy B, et al. Viral Immunol. 2014 Feb;27(1):7-13. doi: 10.1089/vim.2013.0064. Viral Immunol. 2014. PMID: 24494968

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters